India's first indigenous biologic, Biocon's ALZUMAb gets approval for COVID-19 treatment

India's first indigenous biologic, Biocon's ALZUMAb gets approval for COVID-19 treatment: Following the news that India-based biopharma company Biocon’s plaque psoriasis drug itolizumab (ALZUMAb) has secured approval from the Drugs Controller General of India (DCGI) for emergency use in COVID-19 patients;

VARINDIA- INDIA'S FRONTLINE IT MAGAZINE

Comments

Popular posts from this blog

Prizm Payment Services changes its name to Hitachi Payment Services

Japan's Sharp to buy Toshiba PC business for $36 mln